158 results
8-K
EX-10.6
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
not receive the benefit of such more favorable term until a default occurs under such other security) than the rights and benefits established in favor … of the Buyer by this Agreement or any Note unless, in any such case, the Buyer has been provided with such rights and benefits pursuant to a definitive
8-K
EX-10.3
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) of the Code or qualification for the benefits of an income tax treaty to which the United States is a party, and any other form prescribed by applicable
8-K
EX-10.4
xwvu5w2cx6
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
219zzm0
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.3
xe0 qmyu9p9
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-99.1
julwi0wld326bcwm6kb
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
ep7jjudz6 x5g3meocz
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
9ahjkbi86g6oc4fap
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
0s6wi1
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
xefvzcuf6aw08k m7t
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
sp9fvczetvtrv dls
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
5xvuxlz1q1grfh4kbeq
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
2169sxluq7a9tgy
28 Dec 23
Other Events
4:14pm
8-K
EX-99.1
vhwox
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm